Alerts will be sent to your verified email
Verify Email
MERCURYLAB
|
Mercury Laboratories
|
Samrat Pharmachem
|
Asston Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.51 % | 20.36 % | 31.69 % |
|
5yr average Equity Multiplier
|
1.49 | 1.97 | 5.73 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 2.61 | 0.79 |
|
5yr Avg Net Profit Margin
|
6.6 % | 3.99 % | 10.83 % |
|
Price to Book
|
1.94 | 1.46 | 8.96 |
|
P/E
|
33.14 | 14.71 | 22.1 |
|
5yr Avg Cash Conversion Cycle
|
-4.69 Days | 59.17 Days | 121.8 Days |
|
Inventory Days
|
32.68 Days | 27.69 Days | 31.3 Days |
|
Days Receivable
|
115.65 Days | 78.39 Days | 296.65 Days |
|
Days Payable
|
157.73 Days | 45.36 Days | 343.23 Days |
|
5yr Average Interest Coverage Ratio
|
15.15 | 14.72 | 3.57 |
|
5yr Avg ROCE
|
13.49 % | 30.03 % | 42.37 % |
|
5yr Avg Operating Profit Margin
|
11.74 % | 5.83 % | 15.11 % |
|
5 yr average Debt to Equity
|
0.13 | 0.26 | 1.99 |
|
5yr CAGR Net Profit
|
-10.08 % | -12.62 % | 108.46 % |
|
5yr Average Return on Assets
|
7.02 % | 10.58 % | 7.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.66 % | 49.09 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 0.0 | n/a |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.56 % | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | n/a |
|
Mercury Laboratories
|
Samrat Pharmachem
|
Asston Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|